{"transactions":[{"id":725591,"issuer":{"id":3826,"kind":"organization","name":"Stevanato Group S.p.A."},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-26T10:14:41.000Z","date":"2026-06-12","kind":"grant","planned":false,"acquired":true,"shares":4975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents ordinary shares granted as equity compensation in connection with the Reporting Person's service as director"}],"balance_after":6975,"source":{"system":"sec-edgar","filing":"0001193125-26-283812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849853/000119312526283812/ownership.xml","form_type":"4"}},{"id":733116,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T00:47:09.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":4946,"price":24.3807,"value":120586.9422,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on December 4, 2025, by the Reporting Person, with a plan end date of February 19, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $24.045 to $24.62, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":27567,"source":{"system":"sec-edgar","filing":"0001628280-26-044083","document":"wk-form4_1781743626.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026044083/wk-form4_1781743626.xml","form_type":"4"}},{"id":744105,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-10T01:21:26.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":16667,"derivative":{"exercise_price":21.23,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-26-042045","document":"wk-form4_1781054483.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026042045/wk-form4_1781054483.xml","form_type":"4"}},{"id":744104,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T01:21:26.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":5778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 26, 2025, maintained by the Company."}],"balance_after":32513,"source":{"system":"sec-edgar","filing":"0001628280-26-042045","document":"wk-form4_1781054483.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000162828026042045/wk-form4_1781054483.xml","form_type":"4"}},{"id":988312,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T23:27:29.000Z","date":"2025-11-24","kind":"exercise","planned":false,"acquired":false,"shares":7220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service."}],"balance_after":5000,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":7220},"source":{"system":"sec-edgar","filing":"0001867788-25-000005","document":"wk-form4_1764113246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000186778825000005/wk-form4_1764113246.xml","form_type":"4"}},{"id":988311,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-11-25T23:27:29.000Z","date":"2025-11-24","kind":"exercise","planned":false,"acquired":false,"shares":18052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."}],"balance_after":9000,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":18052},"source":{"system":"sec-edgar","filing":"0001867788-25-000005","document":"wk-form4_1764113246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000186778825000005/wk-form4_1764113246.xml","form_type":"4"}},{"id":988310,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:27:29.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":25272,"price":30.7833,"value":777955.5576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $30.56 to $30.91, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $30.56 to $30.91, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":26735,"source":{"system":"sec-edgar","filing":"0001867788-25-000005","document":"wk-form4_1764113246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000186778825000005/wk-form4_1764113246.xml","form_type":"4"}},{"id":988309,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:27:29.000Z","date":"2025-11-24","kind":"exercise","planned":false,"acquired":true,"shares":7220,"price":7.51,"value":54222.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service."}],"balance_after":52007,"source":{"system":"sec-edgar","filing":"0001867788-25-000005","document":"wk-form4_1764113246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000186778825000005/wk-form4_1764113246.xml","form_type":"4"}},{"id":988308,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:27:29.000Z","date":"2025-11-24","kind":"exercise","planned":false,"acquired":true,"shares":18052,"price":8.63,"value":155788.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."}],"balance_after":44787,"source":{"system":"sec-edgar","filing":"0001867788-25-000005","document":"wk-form4_1764113246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000186778825000005/wk-form4_1764113246.xml","form_type":"4"}},{"id":1109356,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-17T00:18:08.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":20568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date."}],"balance_after":20568,"derivative":{"exercise_price":13.5,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":20568},"source":{"system":"sec-edgar","filing":"0002065881-25-000029","document":"wk-form4_1750119481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588125000029/wk-form4_1750119481.xml","form_type":"4"}},{"id":1109355,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T00:18:08.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":7609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on October 21, 2024, maintained by the Company."}],"balance_after":26735,"source":{"system":"sec-edgar","filing":"0002065881-25-000029","document":"wk-form4_1750119481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000206588125000029/wk-form4_1750119481.xml","form_type":"4"}},{"id":1474350,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T20:51:42.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":27052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service."}],"balance_after":27052,"derivative":{"exercise_price":8.63,"expiration_date":"2034-06-14","underlying":"Common Stock","underlying_shares":27052},"source":{"system":"sec-edgar","filing":"0001787306-24-000101","document":"wk-form4_1718743896.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000101/wk-form4_1718743896.xml","form_type":"4"}},{"id":1474349,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-18T20:51:42.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":10139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders.  The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.  The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service."}],"balance_after":19126,"source":{"system":"sec-edgar","filing":"0001787306-24-000101","document":"wk-form4_1718743896.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730624000101/wk-form4_1718743896.xml","form_type":"4"}},{"id":1868928,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T23:22:20.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":12220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023."}],"balance_after":12220,"derivative":{"exercise_price":7.51,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":12220},"source":{"system":"sec-edgar","filing":"0001787306-23-000064","document":"wk-form4_1685748130.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000064/wk-form4_1685748130.xml","form_type":"4"}},{"id":1868927,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T23:22:20.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":8987,"source":{"system":"sec-edgar","filing":"0001787306-23-000064","document":"wk-form4_1685748130.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000178730623000064/wk-form4_1685748130.xml","form_type":"4"}},{"id":2243536,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:54:16.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":11796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 1, 2022."}],"balance_after":11796,"derivative":{"exercise_price":20.29,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":11796},"source":{"system":"sec-edgar","filing":"0001567619-22-012315","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000156761922012315/doc1.xml","form_type":"4"}},{"id":2243535,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T20:54:16.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":4312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,612 Restricted Stock Units (\"RSUs\"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":4612,"source":{"system":"sec-edgar","filing":"0001567619-22-012315","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000156761922012315/doc1.xml","form_type":"4"}},{"id":2665425,"issuer":{"id":4236,"kind":"organization","name":"Arcutis Biotherapeutics, Inc.","symbol":"ARQT"},"owners":[{"id":35172,"kind":"person","name":"LIN SUE-JEAN","position":1,"cik":"0001867788","reported_name":"LIN SUE-JEAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T18:07:34.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":25723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/3rd of the total shares on each of June 9, 2022, June 9, 2023 and June 9, 2024, subject to Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":25723,"derivative":{"exercise_price":27.77,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":25723},"source":{"system":"sec-edgar","filing":"0001567619-21-012178","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1787306/000156761921012178/doc1.xml","form_type":"4"}}]}